Literature DB >> 15367609

Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.

Richard J O Barnard1, Shakti Narayan, Geethanjali Dornadula, Michael D Miller, John A T Young.   

Abstract

A novel entry mechanism has been proposed for the avian sarcoma and leukosis virus (ASLV), whereby interaction with specific cell surface receptors activates or primes the viral envelope glycoprotein (Env), rendering it sensitive to subsequent low-pH-dependent fusion triggering in acidic intracellular organelles. However, ASLV fusion seems to proceed to a lipid mixing stage at neutral pH, leading to the suggestion that low pH might instead be required for a later stage of viral entry such as uncoating (L. J. Earp, S. E. Delos, R. C. Netter, P. Bates, and J. M. White. J. Virol. 77:3058-3066, 2003). To address this possibility, hybrid virus particles were generated with the core of human immunodeficiency virus type 1 (HIV-1), a known pH-independent virus, and with subgroups A or B ASLV Env proteins. Infection of cells by these pseudotyped virions was blocked by lysosomotropic agents, as judged by inhibition of HIV-1 DNA synthesis. Furthermore, by using HIV-1 cores that contain a Vpr-beta-lactamase fusion protein (Vpr-BlaM) to monitor viral penetration into the cytosol, we demonstrated that virions bearing ASLV Env, but not HIV-1 Env, enter the cytosol in a low-pH-dependent manner. This effect was independent of the presence of the cytoplasmic tail of ASLV Env. These studies provide strong support for the model, indicating that low pH is required for ASLV Env-dependent viral penetration into the cytosol and not for viral uncoating.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367609      PMCID: PMC516436          DOI: 10.1128/JVI.78.19.10433-10441.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.

Authors:  N Chazal; G Singer; C Aiken; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

3.  A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.

Authors:  S B Joshi; R E Dutch; R A Lamb
Journal:  Virology       Date:  1998-08-15       Impact factor: 3.616

4.  Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein.

Authors:  W Mothes; A L Boerger; S Narayan; J M Cunningham; J A Young
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

5.  Cell fusion activity of hepatitis C virus envelope proteins.

Authors:  S Takikawa; K Ishii; H Aizaki; T Suzuki; H Asakura; Y Matsuura; T Miyamura
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.

Authors:  T Murakami; E O Freed
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector.

Authors:  B C Lewis; N Chinnasamy; R A Morgan; H E Varmus
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.

Authors:  D J Wyma; A Kotov; C Aiken
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 9.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  21 in total

1.  Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane.

Authors:  Ruben M Markosyan; Fredric S Cohen; Grigory B Melikyan
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

2.  Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM.

Authors:  J Charles Whitbeck; Yi Zuo; Richard S B Milne; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors.

Authors:  Suchita Bhattacharyya; Anna Zagórska; Erin D Lew; Bimmi Shrestha; Carla V Rothlin; John Naughton; Michael S Diamond; Greg Lemke; John A T Young
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

4.  pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion.

Authors:  Tanay M Desai; Mariana Marin; Caleb Mason; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

5.  Imaging individual retroviral fusion events: from hemifusion to pore formation and growth.

Authors:  Gregory B Melikyan; Richard J O Barnard; Levon G Abrahamyan; Walther Mothes; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

6.  Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.

Authors:  Sue E Delos; Bonnie La; Allissia Gilmartin; Judith M White
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

7.  Retroviral host range extension is coupled with Env-activating mutations resulting in receptor-independent entry.

Authors:  Anna Lounková; Jan Kosla; David Přikryl; Kryštof Štafl; Dana Kučerová; Jan Svoboda
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

8.  Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.

Authors:  Weifeng Wang; Jing Zhou; Upul D Halambage; Kellie A Jurado; Augusta V Jamin; Yujie Wang; Alan N Engelman; Christopher Aiken
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

9.  Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

Authors:  Massimo Pizzato; Elena Popova; Heinrich G Göttlinger
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

10.  Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency.

Authors:  Sue E Delos; Matthew B Brecher; Zaoying Chen; Deborah C Melder; Mark J Federspiel; Judith M White
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.